EUVIMEDEUVIMED entdecken
Crossref

Effects of biological agents on lipid profile and hemogram parameters in patients with psoriasis

Kağan Cingöz, Gülsüm Gençoğlan

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-04192-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Kağan Cingöz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Practice, Kagan Cingoz Dermatology Clinic, Kırklareli, Turkey. kagan26@gmail.com. Hauptthemen laut MEDLINE: Psoriasis, Lipids, Biological Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effects of biological agents on laboratory parameters in patients with psoriasis remain incompletely characterized, with conflicting data reported. To investigate the effects of five biological agents on lipid profiles, hemogram parameters, inflammatory markers, and their correlation with disease activity in psoriasis patients. This retrospective study analyzed hemogram parameters (n = 153) and lipid profiles (n = 124) in psoriasis patients treated with adalimumab, etanercept, infliximab, ustekinumab, or secukinumab for ≥ 6 months. Parameters were evaluated at baseline, week 12, and week 24. Patients with conditions potentially affecting these parameters were excluded. Platelet counts decreased significantly in etanercept and secukinumab groups (p < 0.001, p < 0.05) and all patients (p < 0.001). Lymphocyte counts increased in adalimumab and etanercept groups (p < 0.001, p < 0.01) and all patients (p < 0.001). Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio decreased significantly in adalimumab, etanercept, secukinumab groups (p < 0.05). Triglyceride levels increased in the ustekinumab group (10.91%) and all patients (3.2%) (p < 0.05). Total cholesterol, LDL, HDL, and atherogenic index showed no significant changes. A strong positive correlation was found between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio changes (r = 0.646, p < 0.001). Biological agents have specific effects on hematological and lipid parameters in psoriasis patients. The observed changes in inflammatory markers and triglycerides suggest the importance of laboratory monitoring during biological therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisLipidsBiological ProductsHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAntibodies, Monoclonal, HumanizedEtanerceptAdalimumabUstekinumabPlatelet CountAgedInfliximabTreatment OutcomeLymphocytes

Stichwörter der Autor:innen

Biological therapyInflammationLipid profileNeutrophil-to-lymphocyte ratioPlatelet-to-lymphocyte ratioPsoriasis

Substanzen

Antibodies, Monoclonal, HumanizedEtanerceptAdalimumabLipidssecukinumabUstekinumabInfliximabBiological Products

Autor:innen und Institutionen

  • Private Practice, Kagan Cingoz Dermatology Clinic, Kırklareli, Turkey. kagan26@gmail.com.
  • Department of Dermatology and Venereology, Liv Hospital Vadi İstanbul, Istinye University, Istanbul, 34010, Turkey.

Zitieren

APA

Cingöz, K., & Gençoğlan, G. (2025). Effects of biological agents on lipid profile and hemogram parameters in patients with psoriasis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04192-0

Vancouver

Cingöz K, Gençoğlan G. Effects of biological agents on lipid profile and hemogram parameters in patients with psoriasis. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04192-0

BibTeX
@article{Cingz2025,
  author = {Cingöz, Kağan and Gençoğlan, Gülsüm},
  title = {Effects of biological agents on lipid profile and hemogram parameters in patients with psoriasis},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-04192-0}
}
Kostenlos starten →